Close this search box.

Phase 1 (Thoracic)

Phase 1 (Thoracic)

We’re here for you. Call us at 844-346-7222 or

find a clinical trial

If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at (201) 518-3587, or email us at email.

3 Clinical Trials
Phase 1 (Thoracic) Phase I/II Accepting Patients
nct/study# NCT02954523 / CA180-618

Phase I/II Study of Dasatinib and Osimertinib (AZD9291) in Patients With Advanced Non-small Cell Lung Cancer With EGFR Mutations

Learn More
Phase 1 (Thoracic) NA Accepting Patients

Molecular profiling in patients with advanced lung or thymic cancer previously treated with immune checkpoint inhibitor therapy.

Learn More
Phase 1 (Thoracic) Phase II Accepting Patients
nct/study# NCT03516981 / MK-3475-495

A Phase 2 Precision Oncology Study of Biomarker-Directed, Pembrolizumab- (MK-3475, SCH 900475) Based Combination Therapy for Advanced Non-Small Cell Lung Cancer (KEYNOTE-495; KeyImPaCT)

Learn More

We are here for you

For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.

Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.